Blood group biochemistry: A Canadian blood services research and development symposium

Transfusion Medicine Reviews

Volumn 19, Issue 4, 2005, Pages 295-307

  Sheffield, William P ^b   Tinmouth, Alan ^b   Branch, Donald R ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; BLOOD GROUP ANTIGEN; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN; SYNTHETASE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; BIOCHEMISTRY; BIOSYNTHESIS; BLOOD GROUP; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CHROMOSOME 9; CONFERENCE PAPER; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENETICS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; INFECTION SENSITIVITY; MEDICAL RESEARCH; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR INTERACTION; MYCOLOGY; NONHUMAN; PARVOVIRUS; PHENOTYPE; RISK REDUCTION; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOCHEMISTRY; BIOMEDICAL RESEARCH; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; CANADA; HEALTH SERVICES; HUMANS;

EID: 26244468496     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2005.04.005     Document Type: Conference Paper

References (82)

1. M.L. Olsson, C.A. Hill, and H. de la Vega Universal red blood cells-enzymatic conversion of blood group A and B antigens Transfus. Clin. Biol. 11 2004 33 39
2. L.M. Williamson Using haemovigilance data to set blood safety priorities Vox Sang. 83 2002 65 69 (Suppl 1)
3. K.O. Lloyd, E.A. Kabat, and E.J. Layug Immunochemical studies on blood groups. XXXIV. Structures of some oligosaccharides produced by alkaline degradation of blood group A, B, and H substances Biochemistry 5 1966 1489 1501
4. K.O. Lloyd, and E.A. Kabat Some products of the degradation of blood group substances by alkaline borohydride Biochem. Biophys. Res. Commun. 16 1964 385 390
5. H. Clausen, S.B. Levery, and E. Nudelman Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: Chemical basis of qualitative A1 and A2 distinction Proc. Natl. Acad. Sci. U. S. A. 82 1985 1199 1203
6. F. Yamamoto, H. Clausen, and T. White Molecular genetic basis of the histo-blood group ABO system Nature 345 1990 229 233
7. F. Yamamoto, P.D. McNeill, and S. Hakomori Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal Biochem. Biophys. Res. Commun. 187 1992 366 374
8. M.A. Chester, and M.L. Olsson The ABO blood group gene: A locus of considerable genetic diversity Transfus. Med. Rev. 15 2001 177 200
9. J.R. Storry, and M.L. Olsson Genetic basis of blood group diversity Br. J. Haematol. 126 2004 759 771
10. F. Yamamoto, P.D. McNeill, and Y. Kominato Molecular genetic analysis of the ABO blood group system: 2. cis-AB alleles Vox Sang. 64 1993 120 123
11. F. Yamamoto, P.D. McNeill, and M. Yamamoto Molecular genetic analysis of the ABO blood group system: 3. A(X) and B(A) alleles Vox Sang. 64 1993 171 174
12. 2 hybrid allele that causes four missense mutations in the A transferase BMC Genet. 4 2003 17
13. M.L. Olsson, and M.A. Chester Heterogeneity of the blood group Ax allele: Genetic recombination of common alleles can result in the Ax phenotype Transfus. Med. 8 1998 231 238
14. S.I. Patenaude, N.O. Seto, and S.N. Borisova The structural basis for specificity in human ABO(H) blood group biosynthesis Nat. Struct. Biol. 9 2002 685 690
15. M.D. Scott, K.L. Murad, and F. Koumpouras Chemical camouflage of antigenic determinants: Stealth erythrocytes Proc. Natl. Acad. Sci. U. S. A. 94 1997 7566 7571
16. J. Armstrong, R. Wenby, and H. Meiselman In vivo survival of poly(ethylene-glycol)-coated red blood cells in the rabbit Blood 102 2003 320a (abstr)
17. L.L. Lenny, R. Hurst, and A. Zhu Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: Report on the end of phase 1 trials Transfusion 35 1995 899 902
18. L.L. Lenny, R. Hurst, and J. Goldstein Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O Transfusion 34 1994 209 214
19. M.S. Kruskall, J.P. AuBuchon, and K.Y. Anthony Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O Transfusion 40 2000 1290 1298
20. J. Goldstein, G. Siviglia, and R. Hurst Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals Science 215 1982 168 170
21. M.L. Olsson New developments in immunohaematology Vox Sang. 87 2004 66 71 (Suppl 2)
22. Z. Yang, J. Bergstrom, and K.A. Karlsson Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities J. Biol. Chem. 269 1994 14620 14624
23. P.F. Spitalnik, and S.L. Spitalnik The P blood group system: Biochemical, serological, and clinical aspects Transfus. Med. Rev. 9 1995 110 122
24. K.L.P. Landsteiner Further observations on individual differences in human blood Proc. Soc. Exp. Biol. Med. 24 1927 941 942
25. P.B. Levine, O. Bobbitt, and R.K. Waller Isoimmunization of a new blood factor in tumor cells Proc. Soc. Exp. Biol. Med. 77 1951 403 405
26. N.S. Radin Biosynthesis of the sphingoid bases: A provocation J. Lipid Res. 25 1984 1536 1540
27. D.M. Marcus The Ii and P blood group systems Immunol. Ser. 43 1989 701 712
28. 2/P puzzle J. Biol. Chem. 278 2003 44429 44438
29. P.M. Coutinho, E. Deleury, and G.J. Davies An evolving hierarchical family classification for glycosyltransferases J. Mol. Biol. 328 2003 307 317
30. k UDP-galactose: Galbeta-4G1cbeta1-cer alpha1, 4-galactosyltransferase. Molecular genetic basis of the P phenotype J. Biol. Chem. 275 2000 16723 16729
31. T. Okajima, Y. Nakamura, and M. Uchikawa Expression cloning of human globoside synthase cDNAs. Identification of beta 3Gal-T3 as UDP-N- acetylgalactosamine: Globotriaosylceramide beta 1,3-N- acetylgalactosaminyltransferase J. Biol. Chem. 275 2000 40498 40503
32. A. Hellberg, J. Poole, and M.L. Olsson Molecular basis of the globoside-deficient P(k) blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: Globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene J. Biol. Chem. 277 2002 29455 29459
33. W.J. Yount, M.M. Dorner, and H.G. Kunkel Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers J. Exp. Med. 127 1968 633 646
34. M.F. Radermecker, and M.W. Bruwier Pigeon breeder's disease and P blood groups Chest 72 1977 546 547
35. k and early abortion Transfusion 23 1983 350 351
36. R.S. Shirey, P.M. Ness, and T.S. Kickler The association of anti-P and early abortion Transfusion 27 1987 189 191
37. Y. Shechter, I.E. Timor-Tritsch, and N. Lewit Early treatment by plasmapheresis in a woman with multiple abortions and the rare blood group P Vox Sang. 53 1987 135 138
38. G.A. Schwarting, S.K. Kundu, and D.M. Marcus Reaction of antibodies that cause paroxysmal cold hemoglobinuria (PCH) with globoside and Forssman glycosphingolipids Blood 53 1979 186 192
39. S. Degroote, J. Wolthoorn, and G. van Meer The cell biology of glycosphingolipids Semin. Cell Dev. Biol. 15 2004 375 387
40. J.M. Harouse, S. Bhat, and S.L. Spitalnik Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide Science 253 1991 320 323
41. S. Bhat, S.L. Spitalnik, and F. Gonzalez-Scarano Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120 Proc. Natl. Acad. Sci. U. S. A. 88 1991 7131 7134
42. R. Mahfoud, N. Garmy, and M. Maresca Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins J. Biol. Chem. 277 2002 11292 11296
43. R. Mahfoud, M. Mylvaganam, and C.A. Lingwood A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb(3)), eliminates the cholesterol requirement for high affinity gp120/Gb(3) interaction J. Lipid Res. 43 2002 1670 1679
44. N.L. Luban Human parvoviruses: Implications for transfusion medicine Transfusion 34 1994 821 827
45. K.A. Weigel-Kelley, M.C. Yoder, and A. Srivastava Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry Blood 102 2003 3927 3933
46. D.P. Blackall, and M.B. Marques Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation Am. J. Clin. Pathol. 121 2004 S81 S88 (Suppl)
47. K. Sandvig, S. Olsnes, and J.E. Brown Endocytosis from coated pits of Shiga toxin: A glycolipid-binding protein from Shigella dysenteriae 1 J. Cell Biol. 108 1989 1331 1343
48. D.S. Newburg, P. Chaturvedi, and E.L. Lopez Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns J. Infect. Dis. 168 1993 476 479
49. L. Johannes The epithelial cell cytoskeleton and intracellular trafficking. I. Shiga toxin B-subunit system: Retrograde transport, intracellular vectorization, and more Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G1 G7
50. W.E. Smith, A.V. Kane, and S.T. Campbell Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells Infect. Immun. 71 2003 1497 1504
51. O. Kovbasnjuk, M. Edidin, and M. Donowitz Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells J. Cell Sci. 114 2001 4025 4031
52. S. Lee, D. Russo, and C. Redman Functional and structural aspects of the Kell blood group system Transfus. Med. Rev. 14 2000 93 103
53. S. Lee, D. Russo, and C.M. Redman The Kell blood group system: Kell and XK membrane proteins Semin. Hematol. 37 2000 113 121
54. C.M. Westhoff, and M.E. Reid Review: The Kell, Duffy, and Kidd blood group systems Immunohematology 20 2004 37 49
55. S. Lee, E.D. Zambas, and W.L. Marsh Molecular cloning and primary structure of Kell blood group protein Proc. Natl. Acad. Sci. U. S. A. 88 1991 6353 6357
56. S. Lee, A.K. Debnath, and C.M. Redman Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11 Blood 102 2003 3028 3034
57. S. Lee, M. Lin, and A. Mele Proteolytic processing of big endothelin-3 by the Kell blood group protein Blood 94 1999 1440 1450
58. S. Lee Molecular basis of Kell blood group phenotypes Vox Sang. 73 1997 1 11
59. J. Jones, M.E. Reid, and R. Oyen A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens Vox Sang. 69 1995 53 60
60. C. Oefner, A. D'Arcy, and M. Hennig Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon J. Mol. Biol. 296 2000 341 349
61. K. Yazdanbakhsh, S. Lee, and Q. Yu Identification of a defect in the intracellular trafficking of a Kell blood group variant Blood 94 1999 310 318
62. S. Lee, D.C. Russo, and A.P. Reiner Molecular defects underlying the Kell null phenotype J. Biol. Chem. 276 2001 27281 27289
63. K. Yazdanbakhsh, R. Oyen, and Q. Yu High-level, stable expression of blood group antigens in a heterologous system Am. J. Hematol. 63 2000 114 124
64. T. Wagner, B. Resch, and F. Reiterer Pancytopenia due to suppressed hematopoiesis in a case of fatal hemolytic disease of the newborn associated with anti-K supported by molecular K1 typing J. Pediatr. Hematol. Oncol. 26 2004 13 15
65. J.I. Vaughan, M. Manning, and R.M. Warwick Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia N. Engl. J. Med. 338 1998 798 803
66. + human marrow cells in vitro Br. J. Haematol. 127 2004 451 463
67. T. Wagner, G. Lanzer, and K. Geissler Kell expression on myeloid progenitor cells Leuk. Lymphoma 43 2002 479 485
68. G. Daniels, A. Hadley, and C.A. Green Causes of fetal anemia in hemolytic disease due to anti-K Transfusion 43 2003 115 116
69. C.E. van der Schoot, G.H. Tax, and R.J. Rijnders Prenatal typing of Rh and Kell blood group system antigens: The edge of a watershed Transfus. Med. Rev. 17 2003 31 44
70. F. Araujo, C. Pereira, and F. Monteiro Blood group antigen profile predicted by molecular biology-use of real-time polymerase chain reaction to genotype important KEL, JK, RHD, and RHCE alleles Immunohematology 18 2002 59 64
71. A. Danek, J.P. Rubio, and L. Rampoldi McLeod neuroacanthocytosis: Genotype and phenotype Ann. Neurol. 50 2001 755 764
72. M. Ho, J. Chelly, and N. Carter Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein Cell 77 1994 869 880
73. M. Wada, M. Kimura, and M. Daimon An unusual phenotype of McLeod syndrome with late onset axonal neuropathy J. Neurol. Neurosurg. Psychiatry 74 2003 1697 1698
74. B.K. Singleton, C.A. Green, and S. Renaud McLeod syndrome resulting from a novel XK mutation Br. J. Haematol. 122 2003 682 685
75. H.H. Jung, M. Hergerberg, and M. Vogt McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement Transfusion 43 2003 928 938
76. D.C. Russo, S. Lee, and M.E. Reid Point mutations causing the McLeod phenotype Transfusion 42 2002 287 293
77. S. Wendel, R. Fontao-Wendel, and J.E. Levi A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil Transfusion 44 2004 1579 1587
78. R. Oyen, B.L. Powell, and M.E. Reid The first non-CGD McLeod phenotype male to make anti-Kx: Definition of the molecular basis Transfusion 39 1999 90S (abstr)
79. F.F. Wagner, and W.A. Flegel RHD gene deletion occurred in the Rhesus box Blood 95 2000 3662 3668
80. Y. Suto, Y. Ishikawa, and H. Hyodo Gene organization and rearrangements at the human Rhesus blood group locus revealed by fiber-FISH analysis Hum. Genet. 106 2000 164 171
81. F.F. Wagner, B. Ladewig, and K.S. Angert The DAU allele cluster of the RHD gene Blood 100 2002 306 311
82. F.F. Wagner, and W.A. Flegel Review: The molecular basis of the Rh blood group phenotypes Immunohematology 20 2004 23 36